LEX-WK-9YCNS1HCcrawled 2024-04-02 09:14Z
FDA Proposed Rule Establishes Criteria for Difficult Drugs to Compound Under Sections 503A and 503B
Rachael G. Pontikes · Emily L. Hussey · Kelly Kearney · Susan Dewey · Amica Nesbitt · Madhav Bhatt · Health Industry Washington Watch · Published April 2, 2024
Work details
- author
- Rachael G. Pontikes · Emily L. Hussey · Kelly Kearney · Susan Dewey · Amica Nesbitt · Madhav Bhatt
- firm or organization
- Reed Smith LLP
- publication
- Health Industry Washington Watch
- practice area
- Food, Drug & Agriculture
- published
- 2024-04-02
Citation
Rachael G. Pontikes, Emily L. Hussey, Kelly Kearney, Susan Dewey, Amica Nesbitt, Madhav Bhatt, FDA Proposed Rule Establishes Criteria for Difficult Drugs to Compound Under Sections 503A and 503B, Health Industry Washington Watch (April 2, 2024) [The Library at LexBlog, LEX-WK-9YCNS1HC, lexpid.org/9YCNS1HC]